A detailed history of American Century Companies Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 250,939 shares of ITCI stock, worth $21.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
250,939
Previous 268,983 6.71%
Holding current value
$21.4 Million
Previous $18.4 Million 0.4%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$67.99 - $80.84 $1.23 Million - $1.46 Million
-18,044 Reduced 6.71%
250,939 $18.3 Million
Q2 2024

Aug 07, 2024

SELL
$64.76 - $79.84 $17.7 Million - $21.9 Million
-273,930 Reduced 50.46%
268,983 $18.4 Million
Q1 2024

May 14, 2024

BUY
$64.37 - $75.65 $4.03 Million - $4.74 Million
62,663 Added 13.05%
542,913 $37.6 Million
Q4 2023

Feb 13, 2024

BUY
$46.37 - $73.65 $22.3 Million - $35.4 Million
480,250 New
480,250 $34.4 Million
Q3 2023

Nov 13, 2023

BUY
$52.09 - $64.1 $1.13 Million - $1.38 Million
21,604 Added 5.15%
441,410 $23 Million
Q2 2023

Aug 14, 2023

BUY
$54.67 - $66.44 $4.18 Million - $5.08 Million
76,429 Added 22.26%
419,806 $26.6 Million
Q1 2023

May 11, 2023

BUY
$43.8 - $56.99 $162,717 - $211,717
3,715 Added 1.09%
343,377 $18.6 Million
Q4 2022

Feb 13, 2023

BUY
$44.07 - $54.45 $963,678 - $1.19 Million
21,867 Added 6.88%
339,662 $18 Million
Q3 2022

Nov 14, 2022

SELL
$42.7 - $59.99 $64,220 - $90,224
-1,504 Reduced 0.47%
317,795 $14.8 Million
Q2 2022

Aug 12, 2022

BUY
$43.0 - $65.64 $5.53 Million - $8.44 Million
128,636 Added 67.47%
319,299 $18.2 Million
Q1 2022

May 11, 2022

BUY
$38.74 - $62.09 $7.02 Million - $11.2 Million
181,156 Added 1905.5%
190,663 $11.7 Million
Q4 2021

Feb 07, 2022

BUY
$35.2 - $53.42 $31,187 - $47,330
886 Added 10.28%
9,507 $498,000
Q3 2021

Nov 10, 2021

BUY
$28.72 - $42.49 $20,190 - $29,870
703 Added 8.88%
8,621 $321,000
Q2 2021

Aug 05, 2021

BUY
$29.3 - $44.5 $231,997 - $352,351
7,918 New
7,918 $323,000
Q1 2018

May 03, 2018

SELL
$15.16 - $25.49 $990,402 - $1.67 Million
-65,330 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$10.77 - $22.1 $703,604 - $1.44 Million
65,330
65,330 $1.03 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.05B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.